Advertisement
DOV vs EMR
Which Stock Would AI Choose? Dover Corporation (DOV) vs. Emerson Electric (EMR) Stock Comparison
Key Takeaways
- DOV posted double-digit revenue growth in its latest quarter, with bookings up 24% year over year and a book-to-bill ratio above 1.0 across all five segments.
- EMR is leveraging stronger software and recurring-revenue momentum, recently raising its fiscal-year sales and earnings outlook.
- Dover trades at a lower valuation (a price-to-earnings ratio near 23x) than Emerson (near 35x), reflecting different growth profiles and market positioning.
- Both stocks carry a consensus "Buy" rating, but Dover's average analyst price target implies notably more upside than Emerson's.
- Relative performance has diverged: Dover pulled back in recent months, while Emerson has shown steadier recent momentum.
Introduction
Dover Corporation and Emerson Electric are two of the most closely watched names in the industrial and automation sector, yet they pursue different paths to growth. Dover is a diversified manufacturer spanning engineered products, clean energy and fueling, imaging and identification, pumps and process solutions, and climate and sustainability technologies. Emerson is a global automation leader built increasingly around software, control systems, and intelligent devices. For investors weighing a diversified industrial conglomerate against a software-centric automation platform, this stock comparison examines recent performance, relative positioning, and the market sentiment shaping each name in the current environment.
DOV Overview and Recent Performance
DOV, headquartered in Downers Grove, Illinois, is a diversified global manufacturer with annual revenue of more than $8 billion. In its most recent quarterly report, Dover generated revenue of roughly $2.1 billion, up 10% year over year (about 5% organic), with adjusted earnings per share (EPS) rising 11%. Bookings climbed 24% year over year, and management cited a book-to-bill ratio well above 1.0 in all five segments, signaling healthy demand ahead.
Growth has been led by clean energy and climate technologies, including liquid cooling, CO2 refrigeration, and data center infrastructure, along with aerospace and defense within engineered products. Despite this operational momentum, Dover's shares have pulled back in recent weeks and months, trading near the lower half of their 52-week range. The pullback came even as several analysts raised price targets, suggesting sentiment has lagged the company's improving order book and double-digit adjusted EPS growth outlook for the full year.
EMR Overview and Recent Performance
EMR, headquartered in St. Louis, Missouri, positions itself as a global automation leader, with a portfolio spanning intelligent devices, software and systems, and safety and productivity solutions. In its most recent fiscal quarter, Emerson reported revenue of about $4.9 billion, up 7% year over year, with adjusted EPS up roughly 12.5%. Underlying sales rose about 6%, and backlog increased to approximately $8.2 billion, providing visibility into future results.
The standout has been the Software & Systems group, where revenue rose around 11%, supported by test and measurement, power, semiconductor, and aerospace and defense verticals. Recurring software revenue continued to grow, reinforcing Emerson's shift toward higher-margin, subscription-based offerings. Management subsequently raised its full-year outlook for sales growth and adjusted EPS. Emerson's shares have shown relatively steady momentum in recent weeks, supported by broader demand strength in North America, Japan, India, and Southeast Asia, even as Europe and China remain softer.
Trending AI Robots
For traders seeking a data-driven edge, Tickeron's Trending AI Robots page highlights the platform's best-performing AI trading bots for current market conditions. Tickeron hosts hundreds of AI trading bots that collectively trade thousands of different tickers, but only the most suitable ones earn a place in this curated section. These bots vary widely in trading style, strategy, timeframe, performance statistics, and the sets of tickers they trade, with some focusing on short-term momentum and others on longer-horizon positioning. This diversity allows users to align a bot's approach with their own objectives. Explore the Trending AI Robots page to see which strategies are currently leading the pack.
Head-to-Head Comparison
The clearest contrast between these two companies is their business model. Dover is a diversified manufacturer whose growth is tied to secular themes such as electrification, clean energy, climate technology, and data center cooling. Emerson is a more software- and automation-centric platform, with a larger recurring-revenue base and a heavier emphasis on process control and industrial software. Emerson is also a much larger company, with revenue several times Dover's and a market capitalization roughly three to four times greater.
Valuation is another key differentiator. Dover trades at a materially lower price-to-earnings (P/E) multiple than Emerson, reflecting both its slower underlying growth profile in certain segments and its recent share-price pullback. Emerson commands a premium multiple for its software mix and recurring revenue, but that also means more of its future growth may already be reflected in the stock price. On risk factors, Dover faces exposure to short-cycle industrial demand and input-cost pressures, while Emerson must navigate geopolitical disruption, a softer European and Chinese market, and the integration of its software businesses.
Recent momentum also differs. Dover's improving bookings and analyst target increases have not yet translated into sustained share-price strength, whereas Emerson has benefited from steadier demand trends and a raised outlook. From a market sentiment standpoint, both carry consensus "Buy" ratings, but Dover's average price target implies greater potential upside, in part because its valuation has contracted.
Tickeron AI Verdict
Based on observable factors such as trend consistency, stability, catalysts, and relative positioning, Tickeron's AI would likely lean toward DOV in the current environment. The combination of a lower valuation, a rapidly improving order book, and a pullback that has not yet reflected the company's operational momentum presents a more favorable risk-reward profile in probabilistic terms. Emerson's software-driven model and raised guidance support its own constructive case, but its richer multiple reduces the margin for error. This assessment is not investment advice; it reflects a quantitative and probabilistic reading of trend and positioning rather than a definitive prediction of future returns.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOV is a StrongBuy and EMR is a StrongBuy.
DOV in +2.03% Uptrend, growing for three consecutive days on October 29, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where DOV advanced for three days, in 167 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on DOV as a result. In 42 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 52%.
DOV moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for DOV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
The Aroon Indicator entered an Uptrend today. In 85 of 216 cases where DOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 39%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
DOV broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. DOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.632) is normal, around the industry mean (4.242). P/E Ratio (24.849) is within average values for comparable stocks, (38.374). Projected Growth (PEG Ratio) (1.489) is also within normal values, averaging (1.879). Dividend Yield (0.010) settles around the average of (0.030) among similar stocks. P/S Ratio (3.055) is also within normal values, averaging (186.943).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
EMR in upward trend: 10-day moving average broke above 50-day moving average on September 29, 2026
The 10-day moving average for EMR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on EMR as a result. In 62 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for EMR just turned positive on October 27, 2026. Looking at past instances where EMR's MACD turned positive, the stock continued to rise in 30 of 44 cases over the following month. The odds of a continued upward trend are 68%.
Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 217 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 150 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Bearish Trend Analysis
The 10-day RSI Indicator for EMR moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 17 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 40%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 16 (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.515) is normal, around the industry mean (4.242). P/E Ratio (35.935) is within average values for comparable stocks, (38.374). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.013) settles around the average of (0.030) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (186.943).
DOV | EMR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 42 | 29 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 81 Overvalued | |
PROFIT vs RISK RATING 1..100 | 44 | 18 | |
SMR RATING 1..100 | 56 | 62 | |
PRICE GROWTH RATING 1..100 | 45 | 16 | |
P/E GROWTH RATING 1..100 | 37 | 38 | |
SEASONALITY SCORE 1..100 | 85 | 14 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DOV's Valuation (70) in the Miscellaneous Manufacturing industry is in the same range as EMR (81) in the Electrical Products industry. This means that DOV’s stock grew similarly to EMR’s over the last 12 months.
EMR's Profit vs Risk Rating (18) in the Electrical Products industry is in the same range as DOV (44) in the Miscellaneous Manufacturing industry. This means that EMR’s stock grew similarly to DOV’s over the last 12 months.
DOV's SMR Rating (56) in the Miscellaneous Manufacturing industry is in the same range as EMR (62) in the Electrical Products industry. This means that DOV’s stock grew similarly to EMR’s over the last 12 months.
EMR's Price Growth Rating (16) in the Electrical Products industry is in the same range as DOV (45) in the Miscellaneous Manufacturing industry. This means that EMR’s stock grew similarly to DOV’s over the last 12 months.
DOV's P/E Growth Rating (37) in the Miscellaneous Manufacturing industry is in the same range as EMR (38) in the Electrical Products industry. This means that DOV’s stock grew similarly to EMR’s over the last 12 months.
| DOV | EMR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 63% | 2 days ago 40% |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 52% |
| Momentum ODDS (%) | 2 days ago 52% | 2 days ago 68% |
| MACD ODDS (%) | N/A | 2 days ago 68% |
| TrendWeek ODDS (%) | 2 days ago 59% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 50% | 2 days ago 56% |
| Advances ODDS (%) | 3 days ago 54% | 3 days ago 63% |
| Declines ODDS (%) | N/A | 12 days ago 56% |
| BollingerBands ODDS (%) | 2 days ago 46% | 2 days ago 55% |
| Aroon ODDS (%) | 2 days ago 39% | 2 days ago 55% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DOV’s FA Score shows that 0 FA rating(s) are green while EMR’s FA Score has 2 green FA rating(s).
- DOV’s FA Score: 0 green, 5 red.
- EMR’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DOV’s TA Score shows that 5 TA indicator(s) are bullish while EMR’s TA Score has 5 bullish TA indicator(s).
- DOV’s TA Score: 5 bullish, 3 bearish.
- EMR’s TA Score: 5 bullish, 4 bearish.
Price Growth
DOV (@Industrial Machinery) experienced а +4.29% price change this week, while EMR (@Industrial Machinery) price change was +2.07% for the same time period.
The average weekly price growth across all stocks in the @Industrial Machinery industry was -0.31%. For the same industry, the average monthly price growth was -13.39%, and the average quarterly price growth was -19.07%.
Reported Earning Dates
DOV is expected to report earnings on Feb 04, 2027.
EMR is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Industrial Machinery (-0.31% weekly)The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
Advertisement
DOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, DOV has been closely correlated with LECO. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DOV jumps, then LECO could also see price increases.
| Ticker / NAME | Correlation To DOV | 1D Price Change % | ||
|---|---|---|---|---|
| DOV | 100% | -1.25% | ||
| LECO - DOV | 73% Closely correlated | -2.62% | ||
| KMT - DOV | 69% Closely correlated | -3.58% | ||
| ATMU - DOV | 69% Closely correlated | -1.66% | ||
| NDSN - DOV | 68% Closely correlated | -1.95% | ||
| SWK - DOV | 66% Closely correlated | -0.16% | ||
More | ||||